Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
COVID 19 Effect on Cancer Treatment
Study Phase
Study Completion Date
March 2024
NCT04387656Uploaded 04-19-2023
Access via NCI by Request
PDS UID: nci-data-518
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
Provider Information
Provider Data DescriptionThis dataset contains information used in the analyses described and presented in ?COVID-19 severity by vaccination status in patients enrolled to the National Cancer Institute COVID-19 and Cancer Patients Study (NCCAPS)?, including the erratum. Data can be used to approximate published study findings, but exact reproduction of previous manuscripts may not be possible in some cases (e.g., when data must be modified for de-identification purposes or have undergone further data cleaning). Data presented in Figure 1 in the publication are not contained within this data submission, and data presented in Figure 2 have been modified due to de-identification procedures. Specifically, dates of study enrollment and first positive SARS-CoV-2 test have been omitted and year of first positive SARS-CoV-2 test has been substituted for time period of first positive SARS-CoV-2 test.
SponsorNational Cancer Institute (NCI)
Data ProviderNational Cancer Institute
Clinical Trials.gov Information
Brief SummaryThis study collects blood samples, medical information, and medical images from patients who are being treated for cancer and have a positive test for SARS CoV-2, the new coronavirus that causes the disease called COVID-19. Collecting blood samples, medical information, and medical images may help researchers determine how COVID-19 affects the outcomes of patients undergoing cancer treatment and how having cancer affects COVID-19.
ConditionsCOVID-19 Infection
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Metastatic Malignant Solid Neoplasm
Intervention TypeProcedure: Biospecimen Collection
Other: Data Collection
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
Drug(s)N/A
Total Enrolled1917
RandomizationN/A
Blinding MethodN/A
Arms InterventionObservational Cohort (data collection, biospecimen collection) - null
Secondary IDNCI-2020-02986
PubMed (PMID)N/A
Collaborator(s)N/A
Region(s)United States
Canada
Puerto Rico
Age RangeN/A (Child, Adult, Older Adult)
Files: NCT04387656-D1
Data DictionaryNCT04387656-D1-Data-Dictionary_0.pdf
DATANCT04387656-D1-Dataset.csv
OTHERREADME.pdf
© 2024 Project Data Sphere
All rights reserved
Privacy PolicyTerms of Use